Despite considerable efforts that have been made in recent years, our understanding of the molecular mechanisms that are responsible for the intracellular degradation of intracellular protein remains limited. In part, the limitations can be ascribed to the nature of this system, the physiological role of which is to destroy biological active proteins and convert then to amino acids. First, there are difficulties associated with the development of a cell-free system that is capable of complete and controlled degradation of intracellular protein. At the outset, one has to accept the lowered efficiency that arises from the dissociation and dilution of the various components of the system, together with the loss of ultrastructural organization that is clearly a part of the degradation of some, if not all, proteins. A further complication arises from the time scale of the process. The average half-life of intracellular protein is in the region of days in mammalian systems and, thus. in order to measure significant changes in the levels of a protein in a cell-free system, incubation periods of that time scale would be required. Such extended incubations in virro are not usual and raise problems of adventitious autolysis, denaturation, cofactor depletion and instability of enzymes.
Inherently, the need for long incubation periods is linked intrinsically to the destructive nature of the degradative system. Cell-free systems for macromolecular biosynthetic processes are relatively straightforward to monitor because they generate a product that is of highM, and which has the property of 'tangibility', either by virtue of incorporation of a radiolabelled precursor or by reactivity with a suitable detection system (e.g. a specific antibody or a complementary nucleotide sequence). Intracellular protein catabolism results in the loss of tangibility and, thus, the removal of a small fraction of the total pool of undegraded molecules in a short period is unlikely to be measurable, irrespective of the time scale of degradation of individual protein molecules.
At the simplest level, protein degradation can be compartmentalized into the degradative machinery and the protein substrates that are susceptible to that machinery to a greater or lesser extent. The study of bulk proteolysis, usually determined as the appearance of acid-soluble low-M, products derived from a prelabelled protein pool, yields information primarily on the cellular locations and machinery that is responsible for the late events in cellular proteolysis. By contrast, the measurement of the half-life of native individual proteins allows the derivation of the rate but yields little about the route of degradation. However, information on absolute, relative and changing rates of degradation of individual proteins may be correlated with structural properties, permitting some analysis of the features of the substrate that might dispose it to, or protect it from, degradation.
A complete description of the degradative system must include specification of all parts of the catabolic process. Several stages and events can be recognized in conceptual terms. It is convenient to identify a protein as existing in a state that has reversible access to the degradation process and which may, through subtle conformational alterations, be able to control the rate of access: a self-determining regulation of the rate of degradation that allows for integration with other metabolic functions of the cell. At some stage, however, the protein becomes irreversibly committed to degradation in an event that could involve such diverse processes as formation of mixed disulphides, sequestration into autophagic cellular structures, limited proteolysis, membrane association or a number of other events. The early committed step need not involve proteolysis and need not be the step at which the protein is inactivated (functional degradation), although both processes form, by definition, part of the sequence of events that constitute degradation (Beynon, 1980) .
In the final stage of degradation the committed protein is completely hydrolysed to amino acids. The complete proteolysis of a native protein to its component amino acids requires a battery of endopeptidases and exopeptidases of different primary specificities. Further, the complete process must proceed through the formation of intermediate peptides. Attempts to identify such intermediates have been limited but it is generally held that the degradative machinery is assembled in such a way that the committed step is rate-limiting and that intermediates do not accumulate to any great extent. Indeed, the quantity of protein that is turned over in the lifetime of the cell argues most persuasively that the rate-limiting. step in degradation must be an early event; if the converse was true the cell would accumulate large quantities of partially degraded Vol. 13 1005 protein throughout its lifetime, a situation seen when 'abnormal' protein accumulates through the protective device of intracellular precipitation. Although the later stages of intracellular protein degradation must be faster than the early events, a simple kinetic analysis of degradation as a two-step sequential first-order process reinforces the idea that transient intermediates must exist . Further, the intracellular concentration of such intermediates is governed by the relationship between their rate of formation and removal. In as much as information on the size, intracellular localization and intracellular concentrations of these intermediates largely defines the route and rate of catabolism, it is timely to look further at the principles and practice of the identification of such intermediates, particularly those intermediates that mark the proteolytic steps in degradation.
Within the limits allowed by generalization, it would seem reasonable to suggest that approx. 5-15% of all peptide bonds in a protein are susceptible to attack by a single proteolytic enzyme. Thus, digestion of a protein of n amino acids should generate between 4 2 0 and n/6 discrete peptide products. Making the simplifying assumption that all susceptible bonds are hydrolysed at the same rate, the number of sets of intermediates that can be formed (theoretically) as the digestion proceeds is given by T ! / N ! . ( T --N ) ! where T is the total number of susceptible bonds and N is the stage in the digestion at which the Nth bond is hydrolysed. A simple case is illustrated in Fig. 1 , but it is instructive to consider a more realistic physiological situation. A protein consisting of 300 amino acids, digested by a proteinase that can attack 20 peptide bonds in the sequence, will yield 21 limit peptides at the end of reaction. However, if each bond is equally likely to be hydrolysed, the hydrolysis of the 10th peptide bond can theoretically generate approx. 200 000 (= 20!/10! -lo!) different sets of intermediates! Thus, the plethora of potential routes that lead to complete hydrolysis suggest that if all susceptible peptide bonds in a protein are hydrolysed at equal rates, a continuum of intermediates would be generated and, hence, the opportunities for their identification diminish correspondingly. In order to search for degradation intermediates it is necessary to assume that the peptide bonds in the protein differ markedly in their susceptibility to digestion. The extensive literature that describes limited proteolytic reactions acknowledges, implicitly or explicitly, the role of structural factors in determining the extent of proteolytic attack. Any procedure for the generation of a stable proteolytic intermediate of a protein is based upon the principle of cleavage of a susceptible bond to generate a product that is, by virtue of intrinsic structural properties, more resistant to digestion. The susceptible peptide bond can reside in a conformationally mobile part of the structure or in an accessible 'hinge' region and the resistant 'core' can be the remainder of the protein or a tightly folded domain.
The identification of degradation intermediates in vivo is therefore based upon the premise that the structure of the substrate (the protein) will specify a preferential route of proteolysis in the early stages of the catabolic sequence (Fig. 1) . Models of intracellular protein catabolism that imply denaturation (for example, by membrane adsorption or acidification associated with sequestration) make the possibility of discrete intermediates less likely, as the structural features conferring resistance to complete digestion may have been disrupted. It follows that early (possibly cytoplasmic) events in catabolism may be the prime candidates for the generation of detectable intermediates.
Assuming that circumstances can be found where degradation intermediates might be expected to exist, the problem becomes one of identification. As mentioned earlier, initial events in degradation of proteins are associated with loss of tangibility, whether biological activity, size or antigenicity. Coupled with the assumption of low levels of these intermediates in the cell, we might expect that they would only be observed by strategies that are specifically designed for their identification. At present, three approaches seem to offer the greatest opportunities.
Microinjection techniques introduce a prelabelled protein into a cell and permit monitoring of the labelled peptides that are produced as the protein is degraded (McElligot & Dice, 1984; Rechsteiner et al., 1984) . The studies that have been conducted to date have indicated the complexity of the degradative process and suggest that microinjected protein can be compartmentalized and degraded by a specialized route that is activated by this mode of entry of material into cells (Doherty & Mayer, 1985) . If this is the case then the degradation of microinjected proteins may not be representative of normal cytosolic proteins.
Fig. 1. Generation of intermediates during proteolysis
The Figure illustrates a hypothetical and simplified scheme describing the generation of peptide intermediates during the conversion of an intact protein to limit peptides. The case of only four peptide bonds, equally susceptible to digestion, has been assumed for simplicity. At the Nth stage of digestion (at the end of which, N peptide bonds have been hydrolysed) the number of sets of intermediates that can exist is given by 4 ! / N ! * (4 -N ) ! (see text) and thus at the end of each of the four stages, the number of possible sets of intermediates are 4, 6, 4 and 1. (Note that the final stage of digestion yields four products, but they are mutually exclusive and, hence, can be counted as 1 set, in this case, of limit peptides.) In each of the stages the actual number of possible intermediates is larger than the number of possible sets. A route of digestion, such as indicated by the circles, would be dependent upon conformational factors that altered the accessibility of peptide bonds. 613th MEETING, CARDIFF Secondly, a battery of monospecific (or monoclonal) antibodies could in principle be capable of mapping out domains on the surface of the protein. The tendency of the antigenic sites to remain associated during catabolism of a protein would define the sites of cleavage, extensive degradation would be defined by a progressive dissociation of the antigenic sites, probably best detected by immunoblotting methodologies (Gershoni, 1985) . However, recent work has suggested that the strongest immunoreactive sites on the surface of a protein are those that have little or no secondary structure and which have a significant degree of conformational mobility (Westhof et al., 1984; Tainer et al., 1984; Williams & Moore, 1985) . A priori, it might be expected that these could be the same sites that exhibit the greatest proteolytic susceptibility and, thus, loss of epitopes may be an early rather than a late event in degradation. Additional vulnerability may derive from the possibility that epitopes on native proteins often span non-contiguous regions of the polypeptide chain (Atassi, 1984; Amit et al., 1985) . If detection methods are used to identify denatured intermediates it may be advisable to generate the panel of antibodies to an unfolded form of the molecule and to post-select those antibodies that best define individual domains and regions of the parent protein.
A third approach to the identification of degradation intermediates relies upon techniques of specific labelling where the protein is labelled in situ before monitoring of the products of catabolism. The requirements for the specific label are stringent (Butler & Beynon, 1984 , 1985 Beynon et al., 1985) and there are few biological systems that meet these criteria. Among the candidates for specific labelling are irreversible inhibitors (Jones et al., 1983; Crane et al., 1978) , post-translationally modified amino acids and cofactors (Chandler & Ballard, 1983) . Recently, we have proposed that the major muscle enzyme, glycogen phosphorylase, may be a good candidate for specific labelling by its cofactor, pyridoxal phosphate. The levels of glycogen phosphorylase in skeletal muscle and the virtually exclusive association of protein-bound pyridoxal phosphate with this protein suggest that it fulfils the criteria of specificity. We are aware, however, that the relative weakness of the covalent Schiff base linkage between enzyme and cofactor and the possibility of multiple late degradation products (see above) may restrict this system to the identification of early degradation products. Our recent data suggest that the rate of loss of [3H] pyridoxal phosphate label from the protein-bound (= phosphorylase) pool in vivo parallels that for the degradation of the enzyme. This implies that the cofactor does not exchange with the intracellular free pool of cofactor and attests to its suitability as a turnover label. Interestingly, and in contrast to many other pyridoxal phosphate-dependent enzymes, it is not possible to detect apo-phosphorylase in fresh homogenates of skeletal muscle, even after administration of a vitamin B,-deficient diet. Of the two simplest explanations that can be invoked to explain this observation, the first, that apo-phosphorylase is so unstable in vivo as to be degraded extremely rapidly, is not borne out be observations on the proteolytic susceptibility of apo-and holophosphorylases in vitro (Carney et al., 1978) . The second possibility, that the association between the enzyme and cofactor is extremely strong, is supported by observations that resolution of the holoenzyme requires denaturing solvents. We are presently investigating the suitability of pyridoxal phosphate-labelled phosphorylase to identify degradation intermediates that are elicited in normal and pathological conditions. Such studies will help to define restrictions on the routes of degradation of this enzyme and provide an opportunity to test some of the ideas outlined here.
Hepatocy tic protein balance
Rat hepatocytes are particularly suitable for the study of autophagy and protein degradation. Isolated, intact cells can be prepared in high yield from rat liver by the method Abbreviation used: 3MA, 3-methyladenine.
Vol. 13 of collagenase perfusion (Seglen, 1976) , and such cells preserve the characteristic high protein-degrading capacity of the liver as well as its sensitivity towards a variety of biological and pharmacological agents (Seglen et al., 198 1) .
Isolated hepatocytes can be maintained in culture in a defined (serum-free) medium for several weeks, and by the use of sufficiently high amino acid concentrations protein degradation and protein synthesis can be kept in balance so that no net loss of cellular protein occurs (Seglen et al., 1980; Schwarze et al., 1982) . Under amino acid-free conditions, on the other hand, the rate of protein degradation may increase as much as threefold (to about 4%/h),
